Home/Filings/4/0001437749-18-017162
4//SEC Filing

Goodman John B 4

Accession 0001437749-18-017162

CIK 0001443669other

Filed

Sep 17, 8:00 PM ET

Accepted

Sep 18, 4:08 PM ET

Size

11.9 KB

Accession

0001437749-18-017162

Insider Transaction Report

Form 4
Period: 2018-09-14
Transactions
  • Exercise/Conversion

    Common Stock

    2018-09-14$70.00/sh+536$37,52013,191 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-09-145360 total
    Exercise: $70.00Exp: 2025-05-19Common Stock (536 underlying)
  • Exercise/Conversion

    Common Stock

    2018-09-14$62.68/sh+577$36,16612,655 total
  • Sale

    Common Stock

    2018-09-14$162.95/sh1,113$181,36512,078 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-09-145770 total
    Exercise: $62.68Exp: 2024-05-19Common Stock (577 underlying)
Footnotes (4)
  • [F1]Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018.
  • [F2]Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018.
  • [F3]Reflects the weighted average price of 1,113 shares of common stock of Proto Labs, Inc. sold by the reporting person on September 14, 2018 with sale prices ranging from $162.95 to $163.05 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • [F4]Fully vested.

Issuer

Proto Labs Inc

CIK 0001443669

Entity typeother

Related Parties

1
  • filerCIK 0001321965

Filing Metadata

Form type
4
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 4:08 PM ET
Size
11.9 KB